GLRE:NASDAQGreenlight Reinsurance, Ltd. Analysis

Greenlight Capital Re (GLRE) trades around $15.53, comfortably above the calculated support of $14.58 but still below the 20‑day SMA of $16.69 and the 50‑day SMA of $17.53, indicating a modest downside cushion. The RSI of 35 points to a mildly oversold condition, while the MACD remains bearish, suggesting limited short‑term upside momentum. Volatility is elevated at roughly 27% over the past 30 days, yet the beta of 0.28 signals that the stock moves far less than the broader market, reducing systemic risk. Fundamentally, the company appears deeply discounted – a trailing P/E of 6.6 versus an industry average of 17, a price‑to‑book of 0.71 and a price‑to‑sales of 0.73, all well under peer norms. Cash generation is robust, with $75 M in cash, $2.4 B operating cash flow and $275 M free cash flow, while leverage is modest (debt‑to‑equity ~1.0). The recent Q1 2026 earnings beat, a combined ratio improvement to 96% and a $5 M share repurchase reinforce confidence in profitability. However, the DCF‑derived fair value of $111.7 suggests a valuation gap that may not be fully captured by current market sentiment, and the absence of a dividend eliminates income‑focused appeal.